Nelly Alia-Klein, PhD
- ASSOCIATE PROFESSOR | Psychiatry
- ASSOCIATE PROFESSOR | Neuroscience
Research Topics:
Addiction, Brain ImagingOn January 2, 2013, Dr. Alia-Klein was appointed Associate Professor of Psychiatry (primary) and Neuroscience (secondary) at the Icahn School of Medicine at Mount Sinai and co-chief of Neuropsychoimaging of Addiction and Related Conditions (NARC) research program.
Prior to joining Mt. Sinai, Dr. Alia-Klein was Medical Scientist at Brookhaven National Laboratory in New York where she developed a program of study on aggression. She received her PhD from Columbia University in New York City. Dr. Alia-Klein is Principal Investigator on NIMH R01 and co-investigator on several grants from NIDA. As co-chief of NARC, Dr. Alia-Klein works on gene-brain-behavior modeling to predict anger and reactive aggression in clinical diagnoses as Intermittent Explosive Disorder. One of her goals is to further develop understanding and treatment of anger attacks in psychiatric disorders. She published on the neurochemistry modulating these behaviors and the reactivity interplay of prefrontal and subcortical brain regions during provocation or other challenge. Her tools probe select genotypes and their effects on brain function through application of MRI and PET technology. Other topics of study such as sex differences are also of interest, in particular as they affect anger disorders.
In the News
Nova Science Now, PBS series on the neurobiology of violent behavior, title: Can Science Stop Crime? (Aired 10/17/2012)
http://www.pbs.org/wgbh/nova/tech/can-science-stop-crime.html
PBS special After Newtown
http://video.pbs.org/video/2320006234/
Multi-Disciplinary Training Area
Neuroscience [NEU]Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Alia-Klein during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Samaritan Daytop Village
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.